Search results for "Placement."

showing 10 items of 1123 documents

Prevalence and characterization of cardiac involvement in Hunter syndrome.

2011

To assess the prevalence of cardiovascular signs and symptoms in a large group of patients with Hunter syndrome, an X-linked metabolic disorder caused by a deficiency of the lysosomal enzyme iduronate-2-sulfatase.The Hunter Outcome Survey was established to characterize the natural history of Hunter syndrome and to assess the response to enzyme replacement therapy. Echocardiographic and electrocardiographic examination results were available for 102 patients who were enzyme replacement therapy-naïve in the Hunter Outcome Survey (median age at examination, approximately 8 years) as of Jan 23, 2009.The most common cardiovascular finding was valve disease, which was present in 63% of patients.…

AdultMalemedicine.medical_specialtyTime FactorsAdolescentHeart DiseasesIduronate SulfataseLeft ventricular hypertrophyElectrocardiographyYoung AdultRisk FactorsInternal medicineGermanySurveys and QuestionnairesmedicinePrevalenceHumansYoung adultChildMucopolysaccharidosis IIRetrospective Studiesbusiness.industryMetabolic disorderIduronate-2-sulfataseRetrospective cohort studyHunter syndromeEnzyme replacement therapymedicine.diseaseUnited StatesSurgeryNatural historyEchocardiographyChild PreschoolPediatrics Perinatology and Child HealthbusinessFollow-Up StudiesThe Journal of pediatrics
researchProduct

Alterations in speech and voice in patients with mucopolysaccharidoses.

2013

The mucopolysaccharidoses are a group of lysosomal disorders characterized by abnormal accumulation of glycosaminoglycans within cell lysosomes leading to a variety of signs and symptoms including alterations in speech and voice production. These changes were analysed in 44 patients with mucopolysaccharidosis (MPS) types I, II, and VI using standardized protocols. Compared to healthy individuals the diadochokinetic rate for the fast repetition of syllables was slower and more irregular, the voice-onset time for the voiceless consonant /p/ was shorter, and most patients had a hoarse voice. The fundamental frequency (F0) of sustained spoken vowels was in the normal range for most women and ch…

AdultMalemedicine.medical_specialtyTime FactorsAdolescentVoice QualityMucopolysaccharidosisSigns and symptomsAudiologySpeech AcousticsSpeech and HearingYoung AdultSex FactorsArts and Humanities (miscellaneous)PhonationSpeech Production MeasurementmedicineHumansIn patientChildHoarsenessVoice Disordersbusiness.industryVoice-onset timeEnzyme replacement therapyAcousticsMiddle AgedMucopolysaccharidosesLPN and LVNVoice productionmedicine.diseaseHoarse voiceCase-Control StudiesChild PreschoolVoiceAudiometry Pure-ToneFemalemedicine.symptombusinessLogopedics, phoniatrics, vocology
researchProduct

Atherogenic lipoprotein phenotype and low-density lipoprotein size and subclasses in patients with growth hormone deficiency before and after short-t…

2007

Objective: Patients with growth hormone deficiency (GHD) have increased cardiovascular risk and may show elevated triglyceride and reduced high density lipoprotein (HDL) cholesterol concentrations, two lipid abnormalities usually accompanied by increased small dense LDL in the ‘atherogenic lipoprotein phenotype’ (ALP). In the present study, we directly investigated (1) whether hypopituitary patients with GHD have increased small dense LDL; (2) whether growth hormone replacement therapy (GHRT) beneficially impact on such particles; (3) the prevalence of ALP in GHD and GHRT patients. Design and methods: In 14 hypopituitary patients with GHD (44 ± 13 years, body mass index (BMI) 27 ± 3) before…

AdultMalemedicine.medical_specialtyTime FactorsArteriosclerosisHormone Replacement TherapyEndocrinology Diabetes and MetabolismBiologyHypopituitarismGrowth hormone deficiencychemistry.chemical_compoundEndocrinologyInternal medicinemedicineHumansIn patientInsulin-Like Growth Factor ITriglyceridesTriglycerideHuman Growth HormoneCholesterolVascular diseaseCholesterol HDLGeneral MedicineMiddle AgedAtherogenic lipoprotein phenotypemedicine.diseaseLipoproteins LDLCholesterolTreatment OutcomeEndocrinologyAtheromachemistryLow-density lipoproteinElectrophoresis Polyacrylamide GelFemalelipids (amino acids peptides and proteins)European Journal of Endocrinology
researchProduct

Fatty replacement of bone marrow after radiation therapy for Hodgkin disease: Quantification with chemical shift imaging

1993

The authors studied the long-term fatty replacement of bone marrow in 23 patients who had received radiation therapy for Hodgkin disease, with T1-weighted magnetic resonance imaging and quantitative chemical shift imaging. T1-weighted images revealed a mostly homogeneous high-signal-intensity pattern, in contrast to the hypointense pattern of nonirradiated marrow. The degree of fatty replacement was objectively assessed with chemical shift imaging, comparing patients to age-matched healthy volunteers. The authors found an increase in relative fat signal of 37% in the thoracic spine and 34% in the lumbar spine. The relative fat signal of nonirradiated pelvic and femoral marrow was decreased …

AdultMalemedicine.medical_specialtyTime FactorsThoracic spinemedicine.medical_treatmentFatty replacementDiseaseBone MarrowmedicineHumansRadiology Nuclear Medicine and imagingmedicine.diagnostic_testbusiness.industryMagnetic resonance imagingImage EnhancementHodgkin DiseaseMagnetic Resonance ImagingHematopoiesisRadiation therapymedicine.anatomical_structureHomogeneousFemaleBone marrowRadiologyNuclear medicinebusinessChemical shift imagingJournal of Magnetic Resonance Imaging
researchProduct

Dose-Adjusted Thrombosis Prophylaxis in Trauma Surgery According to Levels of D-Dimer

2000

In 234 trauma surgery patients, thrombosis prophylaxis with Nadroparin-Calcium low-molecular-weight heparin (LMWH) was adjusted according to levels of D-Dimer. Basic prophylaxis was 2,850 IU per day. If D-Dimer concentrations rose above 2 mg/L after the fourth postoperative (p.o.) day, LMWH was administered twice a day. Color Doppler ultrasound was performed between the fifth and seventh p.o. days. Patients were divided into a high-risk (group 1: hip, femur, or knee replacement surgery, n=102) and a moderate-risk group (group 2: other surgery of the knee, tibia, fibula, or foot, n=132). Group 1 showed significantly higher D-Dimer levels than group 2 (p0.001). Measurement of D-Dimer on days …

AdultMalemedicine.medical_specialtyTime Factorsmedicine.drug_classmedicine.medical_treatmentDeep veinAntithrombin IIIKnee replacementLow molecular weight heparinSensitivity and SpecificityFibrin Fibrinogen Degradation ProductsFractures BoneRisk FactorsAntifibrinolytic agentD-dimerHumansMedicineAgedAged 80 and overVenous Thrombosisbusiness.industryAnticoagulantNadroparinHematologyMiddle Agedmedicine.diseaseAntifibrinolytic AgentsSurgeryVenous thrombosismedicine.anatomical_structureAnesthesiaWounds and InjuriesFemalebusinessTrauma surgeryBiomarkersLeg InjuriesPeptide HydrolasesThrombosis Research
researchProduct

Does Hybrid Surgery Improve Quality of Life in Multilevel Cervical Degenerative Disk Disease? Five-Year Follow-up Study.

2020

Background: Patient satisfaction is becoming an increasing factor worthy of consideration when evaluating the surgical quality. The correlation between patient satisfaction and surgical outcomes 5 years after cervical hybrid surgery (HS), which incorporates anterior cervical decompression and fusion and cervical disk arthroplasty techniques in multilevel cervical degenerative disk disease, has not been evaluated. Methods: The aim of this study was firstly to analyze prospectively collected data from a sample of patients (n = 50) treated with cervical HS for selected cases of radiculopathy and myelopathy in order to evaluate pain levels of patients, using the Neck and Arm Pain scale as an ex…

AdultMalemedicine.medical_specialtyTotal Disc ReplacementVisual analogue scalemedicine.medical_treatmentDiseaseIntervertebral Disc DegenerationFunctional score03 medical and health sciencesMyelopathyAnterior cervical diskectomy fusion0302 clinical medicinePatient satisfactionPostoperative ComplicationsQuality of lifemedicineHumansRadiculopathyAgedbusiness.industryPain scaleMiddle AgedArtificial disk replacementmedicine.diseaseDecompression SurgicalArthroplastyCombined Modality TherapyMagnetic Resonance ImagingSurgerySpinal FusionTreatment OutcomePatient Satisfaction030220 oncology & carcinogenesisOrthopedic surgeryCervical VertebraeQuality of LifeSurgeryFemaleNeurology (clinical)businessDeglutition DisordersSpinal Cord CompressionHybrid surgery030217 neurology & neurosurgeryFollow-Up StudiesWorld neurosurgery
researchProduct

Enzyme replacement therapy with agalsidase alfa in patients with Fabry's disease: an analysis of registry data

2009

Summary Background We analysed 5-year treatment with agalsidase alfa enzyme replacement therapy in patients with Fabry's disease who were enrolled in the Fabry Outcome Survey observational database (FOS). Methods Baseline and 5-year data were available for up to 181 adults (126 men) in FOS. Serial data for cardiac mass and function, renal function, pain, and quality of life were assessed. Safety and sensitivity analyses were done in patients with baseline and at least one relevant follow-up measurement during the 5 years (n=555 and n=475, respectively). Findings In patients with baseline cardiac hypertrophy, treatment resulted in a sustained reduction in left ventricular mass (LVM) index af…

AdultMalemedicine.medical_specialtyUrologyRenal functionKidney Function TestsMuscle hypertrophyQuality of lifeSurveys and QuestionnairesEpidemiologymedicineHumansRegistriesPain MeasurementVascular diseasebusiness.industryGeneral MedicineEnzyme replacement therapymedicine.diseaseFabry's diseaseFabry diseaseRecombinant ProteinsSurgeryIsoenzymesTreatment Outcomealpha-GalactosidaseHeart Function TestsQuality of LifeFabry DiseaseFemalebusinessThe Lancet
researchProduct

Guided implant surgery with modification of the technique involving the raising of a semicircular miniflap: a preliminary study.

2010

Objective: An evaluation is made of pain, swelling and peri-implant attached mucosal width after implant-based rehabilitation involving guided surgery and a modification of the technique with the raising of a semicircular miniflap, in single and partial replacements. Study design: A case-control study was carried out. The study group consisted of 12 patients with the placement of 19 implants using a guided surgery and miniflap technique. The control group consisted of 12 patients with the placement of 22 implants using the conventional technique. Each patient scored postoperative swelling and pain by means of a visual analog scale (VAS). Attached vestibular mucosa width was evaluated 12 wee…

AdultMalemedicine.medical_specialtyVisual analogue scaleDentistryImplant surgerySurgical FlapsMedicineEdemaHumansGeneral DentistryConventional techniqueVas scoreImplant techniqueVestibular systemPain Postoperativebusiness.industryReview-ArticleMiddle Aged:CIENCIAS MÉDICAS [UNESCO]SurgeryImplant placementDental ImplantationOtorhinolaryngologyCase-Control StudiesUNESCO::CIENCIAS MÉDICASSurgeryFemaleImplantOral SurgerybusinessMedicina oral, patologia oral y cirugia bucal
researchProduct

Comparative, validity and responsiveness of the HOOS-PS and KOOS-PS to the WOMAC physical function subscale in total joint replacement for Osteoarthr…

2009

Udgivelsesdato: 2009-Jul OBJECTIVE: To evaluate the internal consistency of the Hip disability and Osteoarthritis Outcome Score-Physical Function Short-form (HOOS-PS) and the Knee injury and Osteoarthritis Outcome Score-Physical Function Short-form (KOOS-PS) in total hip replacement (THR) and total knee (TKR) replacement. Construct validity and responsiveness were compared to the Western Ontario McMaster Universities' Osteoarthritis Index (WOMAC) Likert 3.0 physical function (PF) subscale and the PF excluding the items in the short measures (PF-exclusions). METHODS: Participants completed the full HOOS or KOOS, measures of fatigue, anxiety, depression and the Chronic Pain Grade (CPG) pre-su…

AdultMalemedicine.medical_specialtyWOMACmedicine.medical_treatmentArthroplasty Replacement HipBiomedical EngineeringOsteoarthritisAnxietySeverity of Illness IndexOsteoarthritis HipValidity03 medical and health sciences0302 clinical medicinePhysical medicine and rehabilitationRheumatologyCronbach's alphaSeverity of illnessActivities of Daily LivingmedicineHumansOrthopedics and Sports MedicineDisabled PersonsArthroplasty Replacement KneeHOOS-PSFatigueTotal joint replacementAgedPain Measurement030203 arthritis & rheumatologyAged 80 and over030222 orthopedicsDepressive Disorderbusiness.industryChronic painConstruct validityResponsivenessMiddle AgedOsteoarthritis Kneemedicine.diseaseKOOS-PSArthroplastyArthralgiaWOMACPhysical therapyAnxietyFemalemedicine.symptombusinessOsteoarthritis and Cartilage
researchProduct

Effects of enzyme replacement therapy on growth in patients with mucopolysaccharidosis type II

2010

Mucopolysaccharidosis type II (MPS II; Hunter syndrome) is an X-linked, recessive, lysosomal storage disorder caused by deficiency of iduronate-2-sulfatase. It has multisystemic involvement, with manifestations in the brain, upper respiratory tract, heart, abdomen, joints and bones. Bone involvement leads to decreased growth velocity and short stature in nearly all patients. A therapeutic option for patients with MPS II is enzyme replacement therapy (ERT) with idursulfase (Elaprase®). We compared annual growth rates before and during ERT in 18 patients from Mainz, Germany, and Manchester, UK. Group 1 included nine patients who started ERT before 10 years of age; group 2 contained nine patie…

AdultMalemedicine.medical_specialtycongenital hereditary and neonatal diseases and abnormalitiesAdolescentIdursulfaseIduronate SulfatasePlaceboShort staturePlacebosYoung AdultChild DevelopmentClinical Trials Phase II as TopicmedicineGeneticsHumansGenetics(clinical)Enzyme Replacement TherapyMucopolysaccharidosis type IIYoung adultGrowth ChartsChildGenetics (clinical)Mucopolysaccharidosis IIbusiness.industrynutritional and metabolic diseasesHunter syndromeEnzyme replacement therapymedicine.diseaseBody HeightSurgerymedicine.anatomical_structureClinical Trials Phase III as TopicAbdomenOriginal Articlemedicine.symptombusinessmedicine.drugJournal of Inherited Metabolic Disease
researchProduct